PT - JOURNAL ARTICLE AU - Van Rijswijk, R. E.N. AU - Tognon, G. AU - Burger, C. W. AU - Baak, J. P. AU - Kenemans, P. AU - Vermorken, J. B. TI - The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract AID - 10.1046/j.1525-1438.1994.04010052.x DP - 1994 Jan 01 TA - International Journal of Gynecologic Cancer PG - 52--60 VI - 4 IP - 1 4099 - http://ijgc.bmj.com/content/4/1/52.short 4100 - http://ijgc.bmj.com/content/4/1/52.full SO - Int J Gynecol Cancer1994 Jan 01; 4 AB - The effect of chemotherapy on the different components of uterine and ovarian carcinosarcoma is largely unknown. This report describes six patients with advanced carcinosarcoma, five of whom received 4 cycles of doxorubicin and ifosfamide (AI) directed at the sarcomatous component of the tumor. Responses in these five patients at second-look laparotomy were: one complete response, two partial responses (persistence of only the carcinomatous component), one stable disease, and one progressive disease (both components still present in both cases). Thereafter 4 cycles of a cisplatin-based regimen were scheduled. Response to the cisplatin-containing regimen was only evaluated clinically. The sixth patient (with no macroscopic disease left after initial surgery) received 6 cycles of a cisplatin-based chemotherapy from the onset and was found to be in complete response at relaparotomy. Median progression-free survival for all patients was 15 months and median survival 21 months. A literature survey showed that carcinosarcoma differs from adult soft tissue sarcomas with respect to responsiveness to chemotherapy. Cisplatin and ifosfamide are active as single agents, whereas the response to single-agent doxorubicin seems to be lower. The data suggest, however, that superior response rates and increased survival times are achieved with cisplatin/doxorubicin-based chemotherapy. The sensitivity of carcinosarcoma to cisplatin supports the recent view that carcinosarcoma of the female genital tract is possibly a high grade carcinoma with metaplastic sarcomatous elements.